🇰🇷 INOTUZUMAB OZOGAMICIN in South Korea

INOTUZUMAB OZOGAMICIN (INOTUZUMAB OZOGAMICIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

INOTUZUMAB OZOGAMICIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is INOTUZUMAB OZOGAMICIN approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for INOTUZUMAB OZOGAMICIN in South Korea?

Marketing authorisation holder not available in our data.